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1. Introduction 
RNAi constitutes a key component of the innate immune response to viral infection in both 
plants and invertebrate animals, and has been postulated to function as the genome or 
intracellular immune system (Fire A., 2005; Plasterk RH., 2002; Umbach JL. & Cullen BR., 
2009). Knockdown of Dicer, the key component of the RNAi pathway, elicits DNA damage 
and induces the expression of MHC class I chain-related gene A and B (MICA and MICB), 
two ligands of the NKG2D receptor expressed by natural killer cells and activated CD8+ T 
cells (Tang KF. et al, 2008b). In this chapter, I discuss the possible molecular mechanisms by 
which decreased Dicer expression elicits DNA damage and induces the expression of MICA 
and MICB. MICA and MICB are frequently up-regulated in epithelial tumors of diverse 
tissue origins (Gasser S. & Raulet DH., 2006). Dicer is down-regulated in most tumor tissues 
(Merritt WM. et al, 2008; Wu JF. et al, 2011), and DNA damage response is activated in 
human tumors and precancerous lesions (Bartkova J. et al, 2005, 2006; DiTullio RA Jr. et al, 
2002; Gorgoulis VG. et al, 2005). Therefore, the possible roles of Dicer, DNA damage, and 
MICA and MICB in tumorigenesis are also discussed.  
2. RNA interference and the intracellular immune system 
Experimental introduction of antisense RNA into cells was once used to interfere with the 
function of endogenous genes (Izant JG. & Weintraub H., 1984; Nellen W. & Lichtenstein 
C., 1993). However, Fire and colleagues found in 1991 that plasmid-encoded sense RNA is 
sufficient to cause interference (Fire A. et al, 1991); Guo and Kemphues reported in 1993 
that, in addition to antisense RNA, sense RNA and double-stranded RNA (dsRNA) 
interfere with the function of endogenous genes (Guo S. & Kemphues KJ., 1995). In 1998, 
Fire and colleagues found that double-stranded RNA is substantially more effective at 
producing interference than either strand individually (Fire A. et al, 1998). After injection 
into adult animals, purified single strands had at most a modest effect, whereas double-
stranded mixtures caused potent and specific interference (Fire A. et al, 1998). This 
phenomenon is now termed RNA interference (RNAi). Historically, RNAi was also 
known as other names, including posttranscriptional gene silencing (PTGS) and co-
suppression in plants (Napoli C. et al, 1990; van der Krol AR. et al, 1990), RNA-mediated 
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virus resistance in plants (Lindbo JA. & Dougherty WG., 1992), and“quelling” in 
Neurospora (Cogoni C., 1996) and algae (Wu-Scharf D. et al, 2000). It was postulated that 
the main functions of the RNAi pathway include antiviral defense, heterochromatic 
silencing, and transposon regulation (Martienssen RA. et al, 2008; Umbach JL. & Cullen 
BR., 2009). Therefore, Plasterk and Fire proposed that RNAi is the genome or intracellular 
immune system (Fire A., 2005; Plasterk RH., 2002).  
3. Dicer is the key component of the RNAi pathway 
RNAi is characterized by the presence of RNAs of about 22 nucleotides in length that are 
homologous to the gene being suppressed (Hamilton AJ. & Baulcombe DC., 1999; 
Hammond SM. et al, 2000; Zamore PD. et al, 2000). These 22-nucleotide sequences, called 
short interfering RNAs (siRNAs), serve as guide sequences that instruct a multicomponent 
nuclease, RNA-Induced Silencing Complex (RISC), to destroy the homologous messenger 
RNAs (Hammond SM. et al, 2000). Dicer, the key component of the RNAi pathway, was 
identified by Bernstein and colleagues (Bernstein E. et al, 2001). They demonstrated that 
immunoprecipitated Dicer can generate 22-nucleotide RNAs from dsRNA substrates, and 
that inhibition of Dicer expression significantly reduces processing of long dsRNA in whole-
cell lysates or in Dicer immunoprecipitates (Bernstein E.et al, 2001). In addition to the 
extrogenous siRNAs, Dicer is also responsible for the biogenesis of endogenous siRNAs. In 
Schizosaccharomyces pombe, Dicer processes endogenous dsRNA derived from 
centromeric repeats. The small RNAs are then associated with Ago1, Chp1, and Tas3 to form 
the RNA-induced initiation of transcriptional gene silencing (RITS) complex that is required 
for heterochromatin assembly in fission yeast (Verdel A. et al, 2004). Deletion of Dicer 
results in the aberrant accumulation of complementary transcripts from centromeric 
heterochromatic repeats. This is accompanied by transcriptional de-repression of transgenes 
integrated at the centromere, loss of histone H3 lysine-9 methylation, and impaired 
centromere function (Volpe TA. et al, 2002). The Drosophila endogenous siRNAs are 
derived from transposons, heterochromatic sequences, and stem-loop structures containing 
RNAs. Normal accumulation of these endogenous siRNAs requires the siRNA-generating 
ribonuclease, Dicer, and the RNA interference effector protein, Ago2; mutations in Dicer 
causes an increase in these transcripts (Czech B. et al, 2008; Ghildiyal M. et al, 2008; 
Kawamura Y. et al, 2008; Okamura K. et al, 2008). SiRNAs are target-dependent amplified in 
some organisms. DsRNA is cut into siRNAs, the double-stranded siRNAs are converted into 
single-stranded siRNAs by the slicer activity of Ago2, the sense strands are degraded, and 
the antisense strands anneal to their targets and induce target degradation. Alternatively, 
the antisense RNAs may serve as primers, inducing dsRNA synthesis by the RNA-
dependent RNA polymerase (RdRP); Dicer then cuts the dsRNAs to generate secondary 
siRNAs (Plasterk RH., 2002). Whether there are endogenous siRNAs in organisms lacking 
RdRP activity was investigated by means of deep sequencing. Two groups found that 
endogenous siRNAs derived from pseudogenes, natural antisense transcripts, and 
transposable elements exist in mouse oocytes (Tam OH. et al, 2008; Watanabe T. et al, 2008). 
In addition to producing siRNA, Dicer is also required for the biogenesis of other types of 
small RNAs. Hutvagner and colleagues presented evidence that in Drosophila, a 
developmentally regulated microRNA (miRNA) precursor, pre-let-7, is cleaved by an RNA 
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interference-like mechanism to produce mature let-7 miRNA (Hutvágner G. et al, 2001). In 
cultured human cells, knockdown of Dicer leads to accumulation of the let-7 precursor. This 
is the first evidence that the RNA interference and miRNA pathways intersect (Hutvágner 
G. et al, 2001). In addition to the biogenesis of siRNAs and miRNAs, Dicer is also required 
for the degradation of unstable RNAs containing AU-rich elements (AREs) in 3-prime 
untranslated regions (UTRs) (Jing Q. et al, 2005). Morever, Dicer also functions in 
fragmenting chromosomal DNA during apoptosis. Nakagawa and colleagues reported that 
inactivation of the Caenorhabditis elegans Dicer gene compromises apoptosis and blocks 
apoptotic chromosome fragmentation (Nakagawa A. et al, 2010). Dicer is cleaved by the 
Ced3 caspase to generate a C-terminal fragment with deoxyribonuclease activity, which 
produces 3-prime hydroxyl DNA breaks on chromosomes and promotes apoptosis 
(Nakagawa A. et al, 2010). 
4. Dicer is essential for heterochromatin formation 
Depletion of Dicer disrupts heterochromatin formation in Schizosaccharomyces pombe, 
Arabidopsis thaliana, Caenorhabditis elegans, Tetrahymena thermophila, and Drosophila 
melanogaster (Grewal SI., 2010; Lejeune E. & Allshire RC., 2011; Martienssen RA. et al, 2008; 
Riddle NC. & Elgin SC., 2008). However, whether Dicer is involved in heterochromatin 
formation in mammalian cells is still controversial. Kanellopoulou and colleagues reported 
that knockout of Dicer in mouse ES cells disrupts centromeric heterochromatin formation, 
with reduced histone H3K9 di-methylation and tri-methylation, reduced DNA methylation, 
and increased levels of centromeric repeat RNAs. The decondensation of heterochromatin is 
accompanied by markedly reduced levels of the 25-30 nt centromeric small dsRNAs, 
suggesting that Dicer-dependant small RNAs are required for the formation of centromeric 
heterochromatin (Kanellopoulou C. et al, 2005). Two groups found that the retinoblastoma-
like 2 protein (Rbl2) is the target of miR-290 family miRNAs, and that Rbl2 can inhibit the 
expression of DNA methyltransferases (Dnmts), including Dnmt1, Dnmt3a and Dnmt3b 
(Benetti R. et al, 2008; Sinkkonen L. et al, 2008). Dicer deficiency in mice leads to decreased 
DNA methylation. DNA-methylation defects correlate with decreased expression of Dnmts 
and miR-290 family miRNAs, and can be reversed by transfection with miR-290 family 
miRNAs. These results indicate that the DNA hypomethylation in Dicer knockout cells is 
the consequence of low levels of miR-290 family miRNAs (Benetti R. et al, 2008; Sinkkonen 
L. et al, 2008). However, Benetti and colleagues found that Dicer is not required for histone 
tri-methylation. They observed that Dicer-null cells have a normal density of H3K9me3 and 
H4K20me3 marks and of HP1-binding at pericentric repeats, and that these heterochromatic 
histone marks are significantly increased at telomeric chromatin in Dicer-null cells 
compared to wild-type controls. They also found that the active chromatin mark, AcH3K9, 
is decreased at Dicer-null telomeres compared to wild-type telomeres, and that the density 
of this mark was not significantly decreased at pericentric chromatin. These results suggest 
that Dicer knockout cells have a higher degree of chromatin compaction and silencing at 
telomeric chromatin (Benetti R. et al, 2008). Hannon’s group reported that although loss of 
Dicer affects the abundance of transcripts from centromeres in mouse ES cells, the histone 
modification status at pericentric repeats and methylation of centromeric DNA are not 
affected in Dicer knockout ES cells (Murchison EP. et al, 2005). Cobb and colleagues 
reported that the maintenance of constitutive and facultative heterochromatin seemed to be 
unperturbed in Dicer knockout thymocytes (Cobb BS. et al, 2005). 
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5. Decreased Dicer expression elicits DNA damage  
The timing of DNA replication is tightly regulated and correlates with chromatin state. 
Highly condensed heterochromatin replicates late in S phase, while less condensed 
euchromatin tends to replicate early (Donaldson AD., 2005). Although the replication times 
of many single copy loci, including a 5 Mb contiguous region surrounding the Rex1 gene, 
are unchanged in Dicer mutant ES cells, the temporal control of satellite DNA replication is 
sensitive to loss of Dicer (Jørgensen HF. et al, 2007). Misregulation of the timing of DNA 
replication may cause stalled and collapsed replication forks, which in turn elicit a DNA 
damage response (Sancar A. et al, 2004). Loss of Dicer in Drosophila cells not only results in 
decondensation of heterochromatin but also leads to accumulation of extrachromosomal 
circular (ecc) repeated DNAs. Ligase IV, an essential regulator of nonhomologous end-
joining and perhaps other DNA damage-repair machinery, participates in eccDNA 
formation (Peng JC. & Karpen GH., 2007). This suggests that, while heterochromatin 
decondensation increases the access of DNA repair and recombination proteins to repeated 
DNA, activation of DNA damage response may also contribute to the formation of eccDNA 
in Dicer mutant cells. RNAi is postulated to function as the genome's immune system, 
defending against molecular parasites such as transposons and viruses, and loss of Dicer 
may activate transposition (Fire A., 2005; Plasterk RH., 2002). Transposition generates 
double strand DNA breaks and elicits a DNA damage response (Gasior SL. et al, 2006). 
Chromatin structure is essential for maintaining genome integrity (Peng JC. & Karpen GH., 
2008). For example, Drosophila cells that lack the Su(var)3-9 H3K9 methyltransferase have 
significantly elevated frequencies of spontaneous DNA damage in heterochromatin. 
Accumulated DNA damage in these mutants correlates with chromosomal defects, such as 
translocations and loss of heterozygosity. Based on the observation that S-phase in Su(var)3-
9 mutants is significantly shorter than that in wild type cells, the authors proposed that 
accumulation of DNA damage in Su(var)3-9 mutants is the consequence of defective DNA 
replication (Peng JC. & Karpen GH., 2009). The regions of repetitive DNA may be 
incompletely replicated or defective in chromatin reassembly because of a shortened S 
phase. Alternatively, repeated DNA in heterochromatin may undergo faster replication, 
resulting in more replication errors. However, the demonstration that DNA damage is 
detected in G1, S, and G2 stages in Su(var)3-9 mutants suggests that defective DNA 
replication is not the only cause of the increased DNA damage. HP1ǃ, whose localization 
requires H3K9me, is needed for efficient DNA damage detection in mammalian cells 
(Ayoub et al, 2008). Therefore, another explanation for the increased frequencies of DNA 
damage in Su(var)3-9 mutant cells may be that proper DNA damage detection and 
subsequent DNA repair response are impaired (Peng JC. & Karpen GH., 2009). We also 
demonstrated that 5-Aza-2'-deoxycytidine (5-aza-dC), a DNA methyltransferase inhibitor, 
induces DNA damage in human cells (Tang KF. et al, 2008a).  
To test whether loss of Dicer can induce DNA damage, we knocked down Dicer in HEK293T 
cells and human hepatoma HepG2 cells and measured markers for DNA damage. 
Immunostaining assays for the phosphorylated form of histone H2AX (Ǆ-H2AX), a widely 
used marker for double-strand DNA breaks (Foster ER. & Downs JA., 2005), and for the 
replication protein A 70 (RPA70), a protein that becomes phosphorylated and forms 
intranuclear foci upon exposure of cells to DNA damage (Zou Y. et al, 2006), revealed that a 
much higher percentage of Dicer knockdown cells display intense Ǆ-H2AX foci and RPA foci 
compared to control cells (Tang KF. et al, 2008b). Using a comet assay to directly assess DNA 
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damage, we confirmed that knockdown of Dicer resulted in accumulation of DNA breaks 
(Tang KF. et al, 2008b). Consistent with our results, Peng and Karpen reported a significant 
increase in spontaneous DNA damage in heterochromatic DNAs of Dicer mutant Drosophila 
cells (Peng JC. & Karpen GH., 2009). Mudhasani and colleagues reported that loss of Dicer 
activates a DNA damage checkpoint, up-regulates p19(Arf)-p53 signaling, and induces 
senescence in primary cells (Mudhasani R. et al, 2008). 
In Figure 1, I summarize the possible mechanisms on how loss of Dicer leads to DNA 
damage. First, loss of Dicer reduces the level of endogenous siRNAs, resulting in 
heterochromatin decondensation. Heterochromatin decondensation may induce DNA 
damage via the following mechanisms: (i) loss of H3K9 methylation compromises DNA 
damage detection and subsequent DNA repair response, leading to DNA damage 
accumulation; (ii) disruption of DNA replication timing induces DNA damage; and (iii) 
mobilization of transposon and retrotransposon creates DNA double-strand breaks. Second, 
loss of Dicer stabilizes dsRNA derived from transposons and retrotransposons, causing a 
high level of transposition and generating DNA double-strand breaks. Third, loss of Dicer 
compromises miRNA biogenesis. Some miRNAs, such as the miR290 family, can suppress 
the expression of DNA methyltransferases or histone modifiers; loss of such miRNAs may 
cause heterochromatin decondensation, which in turn results in DNA damage. Loss of 
miRNAs that target to components of the DNA damage repair pathway may cause 
insufficient DNA damage repair, leading to DNA damage accumulation. These molecular 
events may act synergically or additively in Dicer mutant cells to induce DNA damage. 
 
Fig. 1. Molecular mechanisms of DNA damage arising from decreased Dicer expression. 
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6. DNA damage response induces the expression of ligands for the NKG2D 
receptor 
Natural killer (NK) cells, components of the innate immune system, can kill certain 
transformed or virus-infected cells lacking MHC class I, yet spare the cells expressing MHC 
class I. The ability to attack cells missing ‘self’ markers predicted the existence of both 
inhibitory and activating receptors on NK cells (Lanier LL., 2008). Unlike T and B cells, 
which possess a single antigen receptor that dominates cellular development and activation, 
NK cells do not possess one dominant receptor, but instead have a vast array of receptors to 
initiate effector functions. None of the receptors alone, with the exception of CD16, is able to 
elicit cytolytic activity or cytokine secretion (Lanier LL., 2008). The NKG2D receptor 
complex is one of the activating NK receptors. It is a hexamer, with one NKG2D homodimer 
associated with two DAP10 homodimers. A single gene encodes NKG2D, which is a C-type 
lectin-like superfamily member, and a type II transmembrane-anchored glycoprotein 
expressed as a disulfide-bonded homodimer on the surface of NK cells, Ǆǅ T cells, and CD8+ 
T cells (Lanier LL., 2008). Engagement of NKG2D by its ligands leads either to the direct 
activation of killing and cytokine secretion by NK cells or to a costimulation of cytotoxic T-
lymphocyte cytotoxicity (Lanier LL., 2008; Stern-Ginossar N. & Mandelboim O., 2009). In 
humans, NKG2D ligands are divided into two families: the MHC class I polypeptide-related 
chain (MIC) protein family, which contains MICA and MICB; and the cytomegalovirus 
UL16-binding proteins (ULBP) family, which consists of five members (ULBP1, ULBP2, 
ULBP3, ULBP4, and REAT1G) (Stern-Ginossar N. & Mandelboim O., 2009). 
Gasser and colleagues found that NKG2D ligands are up-regulated in non-tumor cell lines 
by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA 
damage checkpoint pathway (Gasser S. et al, 2005). The DNA damage checkpoints employ 
damage sensor proteins, such as ATM, ATR, the Rad17-RFC complex, and the 9-1-1 
complex, to detect DNA damage and to initiate signal transduction cascades that employ 
Chk1 and Chk2 Ser/Thr kinases and Cdc25 phosphatases. The signal transducers activate 
p53 and inactivate cyclin-dependent kinases to inhibit cell cycle progression from G1 to S 
(the G1/S checkpoint), DNA replication (the intra-S checkpoint), or G2 to mitosis (the G2/M 
checkpoint) (Sancar A. et al, 2004). The up-regulation of NKG2D ligand induced by 
genotoxic stress was prevented by pharmacological or genetic inhibition of ATR, ATM, or 
Chk1, indicating that up-regulation of NKG2D ligands is a consequence of DNA damage 
response (Gasser S. et al, 2005). Induction of DNA damage leads to p53 activation. The role 
of p53 in the up-regulation of NKG2D ligands was addressed by Textor and colleagues. 
They found that induction of wild-type p53, but not mutant p53, strongly up-regulated 
mRNA and cell surface expression of ULBP1 and ULBP2, and that the intronic p53 
responsive elements in these two novel p53 target genes are responsible for the up-
regulation of ULBP1 and ULBP2 (Textor S. et al, 2011). The biological and medical 
implications of these findings have been addressed by several groups. Soriani and 
colleagues demonstrated that treatment with low doses of therapeutic agents such as 
doxorubicin, melphalan, and bortezomib commonly used in the management of patients 
with multiple myeloma leads to up-regulation of NKG2D ligands, and that the drug-
induced expression of NKG2D ligands was abolished after treatment with the ATM and 
ATR pharmacologic inhibitors (Soriani A. et al, 2009). We showed that treatment with 5-
Aza-2'-deoxycytidine (5-aza-dC), a DNA methyltransferase inhibitor, induces DNA 
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damage-dependant up-regulation of NKG2D ligands (Tang KF. et al, 2008a). Cerboni and 
colleagues demonstrated that in response to superantigen, alloantigen, or a specific 
antigenic peptide, the expression of NKG2D ligands on the surface of T lymphocytes is 
induced, and that the induction of NKG2D ligand expression is the consequence of DNA 
damage (Cerboni C. et al, 2007). In addition, they demonstrated that activated T cells became 
susceptible to autologous NK lysis via NKG2D/NKG2DLs interaction and granule exocytosis, 
suggesting that NK lysis of T lymphocytes via NKG2D may be one of the mechanisms limiting 
T-cell responses (Cerboni C. et al, 2007). HIV up-regulates cell-surface expression of NKG2D 
ligands, including ULBP1, ULBP2, and ULBP3, but not MICA or MICB, in infected cells both 
in vitro and in vivo. HIV-1-induced up-regulation of NKG2D ligands contributes to HIV-1-
induced CD4+ T-lymphocyte depletion. Recently, two groups demonstrated that the HIV-1 
Vpr protein activates the DNA damage response, which specifically induces surface 
expression of ULBP1 and ULBP2 (Richard J. et al, 2010; Ward J. et al, 2009).  
7. Decreased Dicer expression elicits up-regulation of MICA and MICB 
The DNA damage pathway regulates expression of innate immune system ligands for the 
NKG2D receptor. Human NKG2D ligands are up-regulated by genotoxic stress and 
stalled DNA replication. Dicer knockdown elicits DNA damage in human cells. These 
observations prompted us to test whether NKG2D ligands were up-regulated in Dicer 
knockdown cells. Quantitative RT-PCR and flow cytometry revealed markedly increased 
levels of MICA and MICB mRNAs and proteins in Dicer knockdown cells compared with 
mock-transfected or control siRNA-transfected cells. In contrast, inhibiting the expression 
of Dicer did not significantly alter the levels of ULBP1, ULBP2, and ULBP3 mRNAs. Up-
regulation of MICA and MICB by Dicer knockdown is prevented by pharmacologic or 
genetic inhibition of DNA damage pathway components, including ATM, ATR, or Chk1. 
This finding suggests that up-regulation of MICA and MICB is the result of DNA damage 
response activated by Dicer knockdown. Dicer knockdown cells also exhibited greater 
sensitivity to lysis by NKL, a cell line derived from an aggressive form of human natural 
killer cell leukemia. Lysis was partially inhibited by anti-NKG2D antibody, which 
indicated that up-regulated NKG2D ligands make the cells more susceptible to lysis by 
NK cells. This result suggests that Dicer-deficient cells may be cleared by NK or other 
immune cells (Tang KF. et al, 2008b).  
Although we have shown that up-regulation of MICA and MICB in Dicer knockdown cells 
is the result of DNA damage response activation, further studies are necessary to determine 
whether other mechanisms are also involved in the regulation of MICA and MICB in Dicer 
knockdown cells. Stern-Ginossar and colleagues reported that one of the human 
cytomegalovirus encoded miRNAs, hcmv-miR-UL112, specifically down-regulates MICB 
expression during viral infection, leading to decreased binding of NKG2D and reduced 
killing by NK cells (Stern-Ginossar N. et al, 2007). The hcmv-miR-UL112 binding site in the 
MICB 3’-untranslated region is conserved among different MICB alleles and a similar site 
exists in the MICA 3’-untranslated region, suggesting that these sites are targeted by cellular 
microRNAs (Stern-Ginossar N. et al, 2007). To test this hypothesis, Stern-Ginossar and 
colleagues expressed MICB with or without its 3’-UTR in primary human foreskin fibroblast 
(HFF) cells. MICB expression was much higher when it was expressed without its 3’-UTR. 
Fusion of the 3’-UTR of MICA to green fluorescent protein (GFP) also inhibited GFP 
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expression. These results indicated that the 3’-UTRs of MICA and MICB inhibit expression 
of the corresponding proteins. Knockdown of Drosha, an enzyme essential for miRNA 
biogenesis (Lee Y. et al, 2003), relieved the inhibitory effects, suggesting that cellular 
microRNAs do indeed regulate MICA and MICB expression. Further studies demonstrated 
that miR-20a, miR-93, miR106b, miR-372, miR-373, and miR-520d are involved in the 
regulation of MICA and MICB expression (Stern-Ginossar N. et al, 2008). Yadav and 
colleagues reported that miR-520b acted on both the MICA 3’-UTR and the promoter 
region, causing a decrease in the levels of the MICA transcript and protein. However, an 
antisense oligonucleotide inhibitor of miR-520b increased the expression of a reporter 
construct containing the MICA 3’-UTR (Yadav D. et al, 2009). Dicer is the key enzyme 
involved in miRNA biogenesis, and knockdown of Dicer reduces levels of miRNAs. 
Therefore, it is conceivable that reduced levels of miRNAs may contribute to the up-
regulation of MICA and MICB in Dicer knockdown cells. 
Interferon-alpha promotes expression of MICA in tumor cells (Zhang C. et al, 2008). Some 
siRNAs are found to activate protein kinase R (PKR) and induce global up-regulation of 
interferon-stimulated genes (Marques JT. & Williams BR., 2005; Sledz CA. et al, 2003). 
Because dsRNAs are natural substrates of Dicer, knockdown of Dicer may stabilize 
endogenous dsRNAs. Elevated levels of endogenous dsRNAs may activate the interferon 
pathway. Therefore, it seems possible that up-regulation of MICA and MICB is the 
consequence of nonspecific activation of the interferon pathway in Dicer knockdown cells. 
Our results indicated that the phosphorylation status of PKR and the expression of 
interferon-stimulated genes are not changed in Dicer knockdown cells compared to control 
cells (Tang KF. et al, 2008b). However, we cannot exclude the possibility that complete 
depletion of Dicer may yield levels of endogenous dsRNAs high enough to activate the 
interferon pathway, and eventually up-regulate the expression of MICA and MICB.  
The expression of MICA and MICB is tightly correlated with cell proliferation status. 
Highly confluent HCT116 cells grown to quiescence contain small amounts of MICA and 
MICB mRNAs and display low MIC surface protein expression. In rapidly proliferating 
cells, MICA and MICB mRNAs and surface proteins are strongly induced (Venkataraman 
GM. et al, 2007). Knockout of Dicer in hepatocytes leads to increased cell proliferation 
(Sekine S. et al, 2009), and Dicer knockdown lung adenocarcinoma (LKR13) cells grow 
faster than control cells (Kumar MS. et al, 2007). Therefore, it is possible that up-
regulation of MICA and MICB is the consequence of increased cell proliferation induced 
by down-regulation of Dicer. 
Further studies are necessary to elucidate why loss of Dicer leads to up-regulation of MICA 
and MICB. Some possible mechanisms, summarized in Figure 2, are as follows: (i) decreased 
Dicer expression elicits DNA damage , which in turn induces up-regulation of MICA and 
MICB; (ii) loss of Dicer impairs biogenesis of miRNAs, some miRNAs, such as miR-20a, 
miR-93, miR106b, miR-372, miR-373, miR-520 and miR-520d, can repress the expression of 
MICA and MICB transcriptionally and posttranscriptionally; (iii) loss of Dicer may result in 
increased cell proliferation, and increased proliferation induces the transcription of MICA 
and MICB; and (iv) loss of Dicer stabilizes endogenous dsRNAs, and increased levels of the 
dsRNAs activate the interferon pathway, which in turn induces the expression of MICA and 
MICB.  
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Fig. 2. Molecular mechanisms linking decreased Dicer expression to increased MICA and 
MICB expression 
8. Dicer, DNA damage, and tumorigenesis 
Compared with normal tissue, miRNAs are generally down-regulated in tumor tissue (Lu J. 
et al, 2005). Levels of Dicer mRNA and protein are decreased in 60% of ovarian-cancer 
specimens. Low Dicer expression is significantly associated with advanced tumor stage and 
poor prediagnosis (Merritt WM. et al, 2008). We found that compared to the adjacent non-
cancerous liver tissues, Dicer mRNA and protein are reduced in hepatocellular carcinoma 
tissues in 34 of 36 patients (Wu JF. et al, 2011). Signs of a DNA damage response, including 
histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding 
protein 1, are widely found in clinical specimens from different stages of human tumors and 
precancerous lesions, but not in normal tissues (Bartkova J. et al, 2005, 2006; DiTullio RA Jr. 
et al, 2002; Gorgoulis VG. et al, 2005). Decreased Dicer expression elicits DNA damage 
(Mudhasani R. et al, 2008; Peng JC. & Karpen GH., 2009; Tang KF. et al, 2008b). Therefore, 
the following questions are intriguing: Is there an association between DNA damage and 
Dicer down-regulation in cancer tissues? If the answer is yes, what is the causal relationship 
between DNA damage and Dicer down-regulation in the process of carcinogenesis? What is 
the role of Dicer in carcinogenesis? 
Kumar and colleagues found that loss of Dicer promotes tumorigenesis (Kumar MS. et al, 
2007). They showed that Dicer knockdown cancer cells had a more pronounced transformed 
phenotype. In animals, Dicer knockdown cells formed tumors with accelerated growth; the 
tumors were also more invasive than control tumors. Furthermore, conditional deletion of 
Dicer enhanced tumor development in a K-Ras–induced mouse model of lung cancer 
(Kumar MS. et al, 2007). Sekine and colleagues disrupted Dicer in hepatocytes using a 
conditional knockout mouse model and found that Dicer elimination induces hepatocyte 
proliferation and overwhelming apoptosis. Unexpectedly, they found that two-thirds of the 
mutant mice spontaneously developed hepatocellular carcinomas (HCCs) at 1 year of age. 
The fact that the majority of Dicer deficient hepatocytes undergo apoptosis and that only a 
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minor subset of Dicer-deficient hepatocytes gives rise to HCCs suggests the requirement of a 
“second hit” that promotes hepatocarcinogenesis in Dicer-deficient hepatocytes (Sekine S. et 
al, 2009). Based on these observations, I propose a simple model to explain how Dicer 
knockout leads to hepatocarinogenesis (Figure 3). Dicer depletion induces DNA damage via 
the mechanisms described in Figure 1, and DNA damage response leads to cell apoptosis or 
senescence. DNA damage may also result in DNA mutation such that cells containing 
oncogenic mutations may escape from apoptosis and senescence, eventually forming cancer.  
 
Fig. 3. Molecular mechanisms of Dicer knockout-induced tumorigenesis 
Oncogene activation leads to augmented numbers of active DNA replicons and to 
alterations in DNA replication fork progression. These alterations activate DNA damage 
response, and eventually cell senescence or apoptosis. Genetic analyses indicate that early in 
tumorigenesis (before genomic instability and malignant conversion), human cells activate 
an ATR/ATM-regulated DNA damage response network that delays or prevents cancer. 
Mutations compromising this DNA damage response network might allow cell 
proliferation, survival, increased genomic instability and tumor progression (Bartkova J. et 
al, 2005, 2006; Di Micco R. et al, 2006). 
Comparison of the mechanisms of oncogene-induced carcinogenesis (Figure 4) and Dicer 
depletion induced carcinogenesis suggests that Dicer is a tumor suppressor gene. However, 
Kumar and colleagues demonstrated that Dicer functions as a haploinsufficient tumor 
suppressor gene (Kumar MS. et al, 2009). Deletion of a single copy of Dicer in tumors from 
Dicerfl/+ animals reduced survival compared with controls. Moreover, tumors from 
Dicerfl/fl animals always maintained one functional Dicer allele; forced deletion of Dicer 
inhibited tumorigenesis. Analysis of human cancer genome copy number data reveals 
frequent deletion of Dicer. However, the gene has not been reported to undergo 
homozygous deletion (Kumar MS. et al, 2009).  
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Fig. 4. Molecular mechanisms of oncogene-induced tumorigenesis 
9. MIC molecules, DNA damage and tumorigenesis 
Although evolved in parallel with the human MHC class I genes, MIC molecules (MICA 
and MICB) are quite different from MHC class I molecules. The characteristics of MIC 
molecules include the lack of association with beta-2-microglobulin, stable expression 
without conventional class I peptide ligands, and the absence of a CD8 binding site. The 
MIC genes are highly polymorphic. Around 60 alleles of MICA and 25 alleles of MICB 
have so far been identified (Bahram S. et al, 1994; Eagle RA. & Trowsdale J., 2007;). T cells 
with variable region V-delta-1 gamma/delta T-cell receptors are distributed throughout 
the human intestinal epithelium and may function as sentinels that respond to self-
antigens. MIC molecules are expressed on the surface of the intestinal epithelium cells, 
and are recognized by intestinal epithelial T cells expressing diverse V-delta-1 
gamma/delta TCRs. These data suggest that MIC molecules may regulate the protective 
responses by the V-delta-1 gamma/delta T cells in the epithelium of the intestinal tract 
(Groh V. et al, 1998). Cytomegalovirus (CMV) infection induces MIC expression and a 
concurrent down-regulation of MHC class I molecules on fibroblasts and endothelial cells 
(Groh V. et al, 2001). Functional analysis of T-cell cytotoxicity against CMV-infected 
fibroblasts showed that early after infection when MIC expression was low, antibodies to 
MHC class I, but not to MIC or NKG2D, could block T cell-mediated cytolysis (Groh V. et 
al, 2001). As MIC expression increased, antibody masking of MIC or NKG2D reduced 
target-cell lysis; anti-MHC class I antibodies further reduced cytolysis. This study 
suggests that MIC molecules are involved in the immune clearance of virus-infected cells 
(Groh V. et al, 2001). MICA binds NKG2D on gamma/delta T cells, CD8+ alpha/beta T 
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cells, and natural killer cells. Engagement of NKG2D activates cytolytic responses of 
gamma/delta T cells and NK cells against transfectants and epithelial tumor cells 
expressing MICA (Bauer S. et al, 1999). These results indicate that MICA and MICB play 
important roles in anti-viral and anti-tumor immune response.  
DNA damage response is activated in clinical specimens from different stages of human 
tumors and precancerous lesions, but not in normal tissues (Bartkova J. et al, 2005, 2006; 
DiTullio RA Jr. et al, 2002; Gorgoulis VG. et al, 2005). Activation of the DNA damage 
response results in cell cycle arrest, senescence, and apoptosis. It was proposed that tumor 
progression requires the appearance of mutations that misregulate the DNA damage 
response pathway, such as p53 mutations, which allay the cell cycle block and allow tumor 
outgrowth (Gasser S. & Raulet DH., 2006; Halazonetis TD., 2004). DNA damage induces up-
regulation of NKG2D ligands (including MICA and MICB). Some components of the DNA 
damage checkpoints, including ATM and ATR (two proteins involved in DNA damage 
detection), and Chk1 (a protein that transduces the DNA damage signal to effector proteins), 
are essential for the up-regulation of NKG2D ligands (Gasser S. et al, 2005; Tang KF. et al, 
2008b). p53 is one of the effector proteins of the DNA damage checkpoints, but is not 
required for up-regulation of NKG2D ligands, as indicated by DNA damage-induced 
expression of the ligands in p53-deficient cell lines (Gasser S. et al, 2005). The fact that other 
components of the DNA damage response, such as ATR and Chk1, are rarely mutated in 
tumors might explain why NKG2D ligands are frequently up-regulated in cancer cells 
(Gasser S. & Raulet DH., 2006; Halazonetis TD., 2004). These findings suggest a possible role 
of the immune system, via the DNA damage response and NKG2D, in the elimination of 
precancerous cells and cancer cells.  
In addition to promoting anti-tumor immune response, MICA and MICB can also suppress 
tumor immune surveillance. MICA associates with endoplasmic reticulum protein-5 (ERP5) 
on the surface of tumor cells, and the association is required for MICA shedding. Detailed 
analysis indicated that ERP5 and membrane-anchored MICA form transitory, mixed 
disulfide complexes, from which soluble MICA is released after proteolytic cleavage near 
the cell membrane. The secreted form of MIC molecules may bind to NKG2D receptor and 
inhibit the killing activity of effector cells (Kaiser BK. et al, 2007). NKG2D binding of MIC 
can induce endocytosis and degradation of NKG2D. In cancer patients, NKG2D expression 
was markedly reduced in both CD8+ tumor-infiltrating T cells and in peripheral blood T 
cells, and the reduction of NKG2D expression is associated with increased level of 
circulating tumor-derived soluble MICA. Down-regulation of NKG2D severely impairs the 
function of tumor antigen-specific effector T cells (Groh V. et al, 2002). MICA can also 
mediate strong suppressive effects on T cell proliferation. Responsiveness to MICA-
mediated suppression involves a receptor other than NKG2D. This finding might explain 
the observation that strong in vivo NKG2D ligand expression, such as in tumor cells, 
sometimes fails to support effective immune responses (Kriegeskorte AK. et al, 2005).  
10. Conclusion 
Dicer is misregulated in tumor tissues, and decreased Dicer expression induces the 
expression of MICA and MICB. MICA and MICB play important roles in anti-tumor 
immune response, and are frequently up-regulated in epithelial tumors of diverse tissue 
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origins. These observations suggest that the intracellular immune system and the innate 
immune system have a good synergistic or additive effect in tumor immune surveillance. In 
addition, decreased Dicer expression elicits DNA damage, which in turn induces cell 
apoptosis and senescence. However, disruption of Dicer in hepatocytes promotes 
hepatocarcinogenesis. Therefore, the role and mechanism of Dicer in tumorigenesis need 
further investigation. 
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